Data gathered: September 16
Alternative Data for Aptevo Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 50 | Sign up | Sign up | Sign up |
| Webpage traffic | 2,000 | Sign up | Sign up | Sign up |
| Employee Rating | 80 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 3 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 11,050 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 72 | Sign up | Sign up | Sign up |
| Linkedin Employees | 60 | Sign up | Sign up | Sign up |
About Aptevo Therapeutics
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.
| Price | $1.50 |
| Target Price | Sign up |
| Volume | 113,560,000 |
| Market Cap | $4.8M |
| Year Range | $1.44 - $99.6 |
| Dividend Yield | 0% |
| PE Ratio | 0 |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Aptevo Therapeutics Inc. (NASDAQ:APVO) Short Interest Up 97.7% in AugustSeptember 15 - ETF Daily News |
|
Aptevo Therapeutics Inc. (NASDAQ:APVO) Sees Large Decrease in Short InterestSeptember 8 - ETF Daily News |
 |
Aptevo Therapeutics expands anti-cancer pipeline with APVO452, APVO451September 4 - Thefly.com |
 |
US stock market today reverse gains: Dow, S&P 500 and Nasdaq pull back from record highs as retail sales surge and Fed rate decision loomsSeptember 16 - The Times of India |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 0 | 49,000 | -49,000 | -6.2M | -6.2M | -8.400 |
| Q1 '25 | 0 | 61,000 | -61,000 | -6.4M | -6.5M | -4.390 |
| Q4 '24 | 0 | 71,000 | -71,000 | -6.3M | -6.3M | -8.940 |
| Q3 '24 | 0 | 54,000 | -54,000 | -5.1M | -5.1M | -0.480 |
| Q2 '24 | 0 | 91,000 | 110,000 | -5.9M | -5.9M | -1.670 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
Read more about Aptevo Therapeutics (APVO) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Aptevo Therapeutics?
The Market Cap of Aptevo Therapeutics is $4.8M.
What is Aptevo Therapeutics' PE Ratio?
As of today, Aptevo Therapeutics' PE (Price to Earnings) ratio is 0.
What is the current stock price of Aptevo Therapeutics?
Currently, the price of one share of Aptevo Therapeutics stock is $1.50.
How can I analyze the APVO stock price chart for investment decisions?
The APVO stock price chart above provides a comprehensive visual representation of Aptevo Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Aptevo Therapeutics shares. Our platform offers an up-to-date APVO stock price chart, along with technical data analysis and alternative data insights.
Does APVO offer dividends to its shareholders?
As of our latest update, Aptevo Therapeutics (APVO) does not offer dividends to its shareholders. Investors interested in Aptevo Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Aptevo Therapeutics?
Some of the similar stocks of Aptevo Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.